Elite Pharmaceuticals, Inc. (ELTP)
0.2891
-0.01
(-2.00%)
USD |
OTCM |
Aug 24, 16:00
Elite Pharmaceuticals Total Liabilities (Quarterly) : 34.84M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 34.84M |
| March 31, 2026 | 40.91M |
| December 31, 2025 | 46.10M |
| September 30, 2025 | 55.66M |
| June 30, 2025 | 63.66M |
| March 31, 2025 | 42.87M |
| December 31, 2024 | 54.31M |
| September 30, 2024 | 40.93M |
| June 30, 2024 | 29.60M |
| March 31, 2024 | 26.07M |
| December 31, 2023 | 28.28M |
| September 30, 2023 | 25.62M |
| June 30, 2023 | 16.38M |
| March 31, 2023 | 11.94M |
| December 31, 2022 | 22.54M |
| September 30, 2022 | 23.15M |
| June 30, 2022 | 22.58M |
| March 31, 2022 | 9.927M |
| December 31, 2021 | 9.157M |
| September 30, 2021 | 10.12M |
| June 30, 2021 | 11.29M |
| March 31, 2021 | 10.04M |
| December 31, 2020 | 12.03M |
| September 30, 2020 | 12.99M |
| June 30, 2020 | 16.03M |
| Date | Value |
|---|---|
| March 31, 2020 | 14.30M |
| December 31, 2019 | 15.01M |
| September 30, 2019 | 12.69M |
| June 30, 2019 | 12.24M |
| March 31, 2019 | 13.01M |
| December 31, 2018 | 12.74M |
| September 30, 2018 | 11.65M |
| June 30, 2018 | 11.50M |
| March 31, 2018 | 12.41M |
| December 31, 2017 | 12.18M |
| September 30, 2017 | 11.92M |
| June 30, 2017 | 16.20M |
| March 31, 2017 | 8.647M |
| December 31, 2016 | 10.15M |
| September 30, 2016 | 12.39M |
| June 30, 2016 | 17.52M |
| March 31, 2016 | 20.72M |
| December 31, 2015 | 29.20M |
| September 30, 2015 | 16.21M |
| June 30, 2015 | 21.58M |
| March 31, 2015 | 25.65M |
| December 31, 2014 | 56.24M |
| September 30, 2014 | 79.25M |
| June 30, 2014 | 108.42M |
| March 31, 2014 | 105.52M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Nektar Therapeutics | 192.01M |
| Daré Bioscience, Inc. | 22.93M |
| Eton Pharmaceuticals, Inc. | 69.22M |
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 139.67M |
| Shareholders Equity (Quarterly) | 104.83M |
| Debt to Equity Ratio | 0.0532 |
| Current Ratio | 3.761 |
| Net Debt Paydown Yield | 0.27% |